US Stock MarketDetailed Quotes

Atara Biotherapeutics (ATRA)

Watchlist
  • 4.540
  • -0.080-1.73%
Close Jan 16 16:00 ET
  • 4.630
  • +0.090+1.98%
Post 19:52 ET
32.73MMarket Cap1.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atara Biotherapeutics (ATRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-91.41%3.45M
-38.63%17.58M
258.77%98.15M
1,404.02%128.94M
670.30%32.75M
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
-86.51%8.57M
1,823.98%4.25M
Operating revenue
-91.41%3.45M
-38.63%17.58M
258.77%98.15M
1,404.02%128.94M
670.30%32.75M
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
-86.51%8.57M
1,823.98%4.25M
Cost of revenue
-98.49%115K
-88.03%554K
929.67%20.44M
136.43%21.01M
115.03%6.8M
190.71%7.6M
59.83%4.63M
818.98%1.99M
8.89M
3.16M
Gross profit
-89.76%3.34M
-29.12%17.02M
206.28%77.71M
34,582.75%107.93M
2,277.11%25.96M
6,931.87%32.59M
1,339.06%24.01M
2,412.08%25.37M
-100.49%-313K
394.12%1.09M
Operating expense
-87.28%6.91M
-68.65%13.25M
-31.28%38.91M
-30.59%191.37M
-37.50%38.16M
-21.39%54.35M
-39.20%42.24M
-25.53%56.62M
-19.88%275.69M
-19.41%61.05M
Selling and administrative expenses
-61.74%3.99M
-33.40%5.94M
3.26%11.48M
-21.65%39.89M
-17.58%9.44M
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
-28.85%50.91M
-13.52%11.45M
-General and administrative expense
-61.74%3.99M
-33.40%5.94M
3.26%11.48M
-21.65%39.89M
-17.58%9.44M
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
-28.85%50.91M
-13.52%11.45M
Research and development costs
-93.34%2.93M
-78.07%7.31M
-39.72%27.43M
-32.61%151.48M
-42.09%28.72M
-22.79%43.92M
-40.63%33.33M
-26.79%45.51M
-17.52%224.79M
-20.66%49.6M
Operating profit
83.57%-3.57M
120.71%3.78M
224.18%38.8M
69.77%-83.44M
79.65%-12.2M
68.75%-21.76M
74.47%-18.23M
58.35%-31.25M
1.61%-276.01M
20.62%-59.96M
Net non-operating interest income expense
2.62%-705K
-2.09%-829K
-42.26%-781K
-1,876.60%-2.51M
9.68%-420K
-309.04%-724K
-356.15%-812K
-217.81%-549K
-94.75%141K
-144.80%-465K
Non-operating interest income
-55.56%204K
-68.22%143K
-60.93%236K
-61.11%2.11M
-16.03%597K
-62.32%459K
-73.45%450K
-66.48%604K
77.38%5.43M
-38.44%711K
Non-operating interest expense
-23.16%909K
-22.98%972K
-11.80%1.02M
-12.68%4.62M
-13.52%1.02M
-15.20%1.18M
-8.42%1.26M
-13.70%1.15M
1,316.89%5.29M
905.13%1.18M
Other net income (expense)
-99.28%4K
-9,183.33%-557K
-116.18%-11K
314.63%528K
-641.67%-89K
2,155.56%555K
40.00%-6K
134.52%68K
-100.50%-246K
82.61%-12K
Special income (charges)
----
---579K
----
----
----
----
--0
----
----
----
-Less：Restructuring and merger&acquisition
----
--579K
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-99.28%4K
466.67%22K
-116.18%-11K
314.63%528K
-641.67%-89K
2,155.56%555K
40.00%-6K
134.52%68K
64.86%-246K
82.61%-12K
Income before tax
80.50%-4.28M
112.55%2.39M
219.80%38.01M
69.06%-85.42M
78.97%-12.71M
68.59%-21.93M
73.21%-19.05M
57.55%-31.73M
-20.95%-276.11M
18.95%-60.44M
Income tax
264.71%28K
3K
0
-180.00%-12K
-272.73%-19K
10.53%-17K
0
9.09%24K
25.00%15K
450.00%11K
Net income
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
Net income continuous Operations
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
Minority interest income
Net income attributable to the parent company
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
Basic earnings per share
89.08%-0.32
106.45%0.2
162.48%3.53
82.50%-11.41
91.45%-1.19
82.13%-2.93
81.67%-3.1
68.61%-5.65
-16.41%-65.19
22.67%-13.92
Diluted earnings per share
89.08%-0.32
106.13%0.19
161.95%3.5
82.50%-11.41
91.45%-1.19
82.13%-2.93
81.67%-3.1
68.61%-5.65
-16.41%-65.19
22.67%-13.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -91.41%3.45M-38.63%17.58M258.77%98.15M1,404.02%128.94M670.30%32.75M1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M-86.51%8.57M1,823.98%4.25M
Operating revenue -91.41%3.45M-38.63%17.58M258.77%98.15M1,404.02%128.94M670.30%32.75M1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M-86.51%8.57M1,823.98%4.25M
Cost of revenue -98.49%115K-88.03%554K929.67%20.44M136.43%21.01M115.03%6.8M190.71%7.6M59.83%4.63M818.98%1.99M8.89M3.16M
Gross profit -89.76%3.34M-29.12%17.02M206.28%77.71M34,582.75%107.93M2,277.11%25.96M6,931.87%32.59M1,339.06%24.01M2,412.08%25.37M-100.49%-313K394.12%1.09M
Operating expense -87.28%6.91M-68.65%13.25M-31.28%38.91M-30.59%191.37M-37.50%38.16M-21.39%54.35M-39.20%42.24M-25.53%56.62M-19.88%275.69M-19.41%61.05M
Selling and administrative expenses -61.74%3.99M-33.40%5.94M3.26%11.48M-21.65%39.89M-17.58%9.44M-14.91%10.42M-33.17%8.91M-19.89%11.11M-28.85%50.91M-13.52%11.45M
-General and administrative expense -61.74%3.99M-33.40%5.94M3.26%11.48M-21.65%39.89M-17.58%9.44M-14.91%10.42M-33.17%8.91M-19.89%11.11M-28.85%50.91M-13.52%11.45M
Research and development costs -93.34%2.93M-78.07%7.31M-39.72%27.43M-32.61%151.48M-42.09%28.72M-22.79%43.92M-40.63%33.33M-26.79%45.51M-17.52%224.79M-20.66%49.6M
Operating profit 83.57%-3.57M120.71%3.78M224.18%38.8M69.77%-83.44M79.65%-12.2M68.75%-21.76M74.47%-18.23M58.35%-31.25M1.61%-276.01M20.62%-59.96M
Net non-operating interest income expense 2.62%-705K-2.09%-829K-42.26%-781K-1,876.60%-2.51M9.68%-420K-309.04%-724K-356.15%-812K-217.81%-549K-94.75%141K-144.80%-465K
Non-operating interest income -55.56%204K-68.22%143K-60.93%236K-61.11%2.11M-16.03%597K-62.32%459K-73.45%450K-66.48%604K77.38%5.43M-38.44%711K
Non-operating interest expense -23.16%909K-22.98%972K-11.80%1.02M-12.68%4.62M-13.52%1.02M-15.20%1.18M-8.42%1.26M-13.70%1.15M1,316.89%5.29M905.13%1.18M
Other net income (expense) -99.28%4K-9,183.33%-557K-116.18%-11K314.63%528K-641.67%-89K2,155.56%555K40.00%-6K134.52%68K-100.50%-246K82.61%-12K
Special income (charges) -------579K------------------0------------
-Less：Restructuring and merger&acquisition ------579K------------------0------------
Other non- operating income (expenses) -99.28%4K466.67%22K-116.18%-11K314.63%528K-641.67%-89K2,155.56%555K40.00%-6K134.52%68K64.86%-246K82.61%-12K
Income before tax 80.50%-4.28M112.55%2.39M219.80%38.01M69.06%-85.42M78.97%-12.71M68.59%-21.93M73.21%-19.05M57.55%-31.73M-20.95%-276.11M18.95%-60.44M
Income tax 264.71%28K3K0-180.00%-12K-272.73%-19K10.53%-17K09.09%24K25.00%15K450.00%11K
Net income 80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M
Net income continuous Operations 80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M
Minority interest income
Net income attributable to the parent company 80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M
Basic earnings per share 89.08%-0.32106.45%0.2162.48%3.5382.50%-11.4191.45%-1.1982.13%-2.9381.67%-3.168.61%-5.65-16.41%-65.1922.67%-13.92
Diluted earnings per share 89.08%-0.32106.13%0.19161.95%3.582.50%-11.4191.45%-1.1982.13%-2.9381.67%-3.168.61%-5.65-16.41%-65.1922.67%-13.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -